UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 30

Sortiert nach

Management of HER2 alterations in non-small cell lung cancer – The past, present, and future

Lung cancer (Amsterdam, Netherlands), 2023-12, Vol.186, p.107385-107385, Article 107385

2023

Volltextzugriff (PDF)

Resectable non-small cell lung cancer: an evolving landscape

Translational lung cancer research, 2022-07, Vol.11 (7), p.1241-1246

2022

Volltextzugriff (PDF)

Assessment of Spinal Muscular Atrophy Carrier Status by Determining SMN1 Copy Number Using Dried Blood Spots

International journal of neonatal screening, 2020-06, Vol.6 (2), p.43-43

2020

Volltextzugriff (PDF)

A step towards the ambition of precision oncology in recurrent ovarian cancer

Journal of Gynecologic Oncology, 2022, 33(4), , pp.1-4

2022

Volltextzugriff (PDF)

Glycogen Storage Disease Type Ia Screening Using Dried Blood Spots on Filter Paper: Application of COP-PCR for Detection of the c.648G>T G6PC Gene Mutation

Kobe journal of the medical sciences, 2021, Vol.67 (2), p.E71-E78

2021

Volltextzugriff (PDF)

Intron-retained transcripts of the spinal muscular atrophy genes, SMN1 and SMN2

Brain & development (Tokyo. 1979), 2018-09, Vol.40 (8), p.670-677

2018

Volltextzugriff (PDF)

Phosphoethanolamine Elevation in Plasma of Spinal Muscular Atrophy Type 1 Patients

Kobe journal of the medical sciences, 2020, Vol.66 (1), p.E1-E11

2020

Volltextzugriff (PDF)

Newborn Screening for Spinal Muscular Atrophy: DNA Preparation from Dried Blood Spot and DNA Polymerase Selection in PCR

Kobe journal of the medical sciences, 2019, Vol.65 (3), p.E95-E99

2019

Volltextzugriff (PDF)

Nested PCR Amplification Secures DNA Template Quality and Quantity in Real-time mCOP-PCR Screening for SMA

Kobe journal of the medical sciences, 2019, Vol.65 (2), p.E54-E58

2019

Volltextzugriff (PDF)

PCR-Based Screening of Spinal Muscular Atrophy for Newborn Infants in Hyogo Prefecture, Japan

Genes, 2022-11, Vol.13 (11), p.2110

2022

Volltextzugriff (PDF)

High Concentration or Combined Treatment of Antisense Oligonucleotides for Spinal Muscular Atrophy Perturbed SMN2 Splicing in Patient Fibroblasts

Genes, 2022-04, Vol.13 (4), p.685

2022

Volltextzugriff (PDF)

Stability and Oligomerization of Mutated SMN Protein Determine Clinical Severity of Spinal Muscular Atrophy

Genes, 2022-01, Vol.13 (2), p.205

2022

Volltextzugriff (PDF)

Spinal Muscular Atrophy: Diagnosis, Incidence, and Newborn Screening in Japan

International journal of neonatal screening, 2021-07, Vol.7 (3), p.45

2021

Volltextzugriff (PDF)

DBS Screening for Glycogen Storage Disease Type 1a: Detection of c.648G>T Mutation in G6PC by Combination of Modified Competitive Oligonucleotide Priming-PCR and Melting Curve Analysis

International journal of neonatal screening, 2021-11, Vol.7 (4), p.79

2021

Volltextzugriff (PDF)

A Novel System for Spinal Muscular Atrophy Screening in Newborns: Japanese Pilot Study

International journal of neonatal screening, 2019-12, Vol.5 (4), p.41-41

2019

Volltextzugriff (PDF)

Corrigendum to “Chemotherapy response score (CRS) as a surrogate marker for homologous recombination deficiency (HRD) based on loss of heterozygosity (LOH) in high grade serous ovarian cancer (HGSOC) (165)” [Gynecologic Oncology Volume 166, Supplement 1, August 2022, Page S98]

Gynecologic oncology, 2023-03, Vol.170, p.333-333

2023

Volltextzugriff (PDF)

Clinical phenotypes of spinal muscular atrophy patients with hybrid SMN gene

Brain & development (Tokyo. 1979), 2021-02, Vol.43 (2), p.294-302

2021

Volltextzugriff (PDF)

Chemotherapy response score (CRS) as a surrogate marker for homologous recombination deficiency (HRD) based on loss of heterozygosity (LOH) in high grade serous ovarian cancer (HGSOC) (165)

Gynecologic oncology, 2022-08, Vol.166, p.S98

2022

Volltextzugriff (PDF)

531 Loss-of-heterozygosity as a biomarker for genomic instability and poor outcomes in endometrial cancer

International journal of gynecological cancer, 2024-03, Vol.34 (Suppl 1), p.A498-A498

2024

Volltextzugriff (PDF)

The role of molecular tests for adjuvant and post-surgical treatment in gynaecological cancers

Best practice & research. Clinical obstetrics & gynaecology, 2022-01, Vol.78, p.14-35

2022

Volltextzugriff (PDF)

A step towards the ambition of precision oncology in recurrent ovarian cancer

Journal of gynecologic oncology, 2022-07, Vol.33 (4), p.1-4

2022

Volltextzugriff (PDF)

Comprehensive characterization of genomic features and clinical outcomes following targeted therapy and secondary cytoreductive surgery in OCCC: a single center experience

Journal of gynecologic oncology, 2024-03, Vol.35

2024

Volltextzugriff (PDF)

Cardiopulmonary resuscitation discussions with patients admitted to acute oncology wards: A national audit of current practice

European journal of cancer care, 2020-05, Vol.29 (3), p.e13218-n/a

2020

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(30)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Management of HER2 alterations in non-small cell lung cancer – The past, present, and future

Resectable non-small cell lung cancer: an evolving landscape

Assessment of Spinal Muscular Atrophy Carrier Status by Determining SMN1 Copy Number Using Dried Blood Spots

A step towards the ambition of precision oncology in recurrent ovarian cancer

Glycogen Storage Disease Type Ia Screening Using Dried Blood Spots on Filter Paper: Application of COP-PCR for Detection of the c.648G>T G6PC Gene Mutation

Intron-retained transcripts of the spinal muscular atrophy genes, SMN1 and SMN2

Phosphoethanolamine Elevation in Plasma of Spinal Muscular Atrophy Type 1 Patients

Newborn Screening for Spinal Muscular Atrophy: DNA Preparation from Dried Blood Spot and DNA Polymerase Selection in PCR

Nested PCR Amplification Secures DNA Template Quality and Quantity in Real-time mCOP-PCR Screening for SMA

PCR-Based Screening of Spinal Muscular Atrophy for Newborn Infants in Hyogo Prefecture, Japan

High Concentration or Combined Treatment of Antisense Oligonucleotides for Spinal Muscular Atrophy Perturbed SMN2 Splicing in Patient Fibroblasts

Correction: Noguchi et al. PCR-Based Screening of Spinal Muscular Atrophy for Newborn Infants in Hyogo Prefecture, Japan. Genes 2022, 13 , 2110

Stability and Oligomerization of Mutated SMN Protein Determine Clinical Severity of Spinal Muscular Atrophy

Spinal Muscular Atrophy: Diagnosis, Incidence, and Newborn Screening in Japan

DBS Screening for Glycogen Storage Disease Type 1a: Detection of c.648G>T Mutation in G6PC by Combination of Modified Competitive Oligonucleotide Priming-PCR and Melting Curve Analysis

A Novel System for Spinal Muscular Atrophy Screening in Newborns: Japanese Pilot Study

Corrigendum to “Chemotherapy response score (CRS) as a surrogate marker for homologous recombination deficiency (HRD) based on loss of heterozygosity (LOH) in high grade serous ovarian cancer (HGSOC) (165)” [Gynecologic Oncology Volume 166, Supplement 1, August 2022, Page S98]

Clinical phenotypes of spinal muscular atrophy patients with hybrid SMN gene

Chemotherapy response score (CRS) as a surrogate marker for homologous recombination deficiency (HRD) based on loss of heterozygosity (LOH) in high grade serous ovarian cancer (HGSOC) (165)

531 Loss-of-heterozygosity as a biomarker for genomic instability and poor outcomes in endometrial cancer

The role of molecular tests for adjuvant and post-surgical treatment in gynaecological cancers

A step towards the ambition of precision oncology in recurrent ovarian cancer

Comprehensive characterization of genomic features and clinical outcomes following targeted therapy and secondary cytoreductive surgery in OCCC: a single center experience

Cardiopulmonary resuscitation discussions with patients admitted to acute oncology wards: A national audit of current practice

Correction: Noguchi et al. PCR-Based Screening of Spinal Muscular Atrophy for Newborn Infants in Hyogo Prefecture, Japan. IGenes/I 2022, I13/I, 2110

Suchergebnisse filtern